ECONOMY & MARKETS

More news

How the US government scams Treasury holders

The US government can’t possibly pay back its $14-trillion debt. Not fairly, at least. Instead, its strategy is to devalue the US dollar so that the nominal value of the $14-trillion debt becomes less in real terms.

Yen forecast: time to buy USD/JPY

The Japanese yen has been on a wild ride ever since the 2011 T?hoku earthquake. Now, as USD/JPY hovers around 80, it’s time to sell the yen (by buying USD/JPY), stated a Credit Agricole report.

Rise and rise of gold: Will prices hit $2,500 on 'insatiable' Chinese demand?

Investors around the world, more so the Chinese, are buying up gold assets to cover against rising inflation risk, macroeconomic uncertainties, a possible currency doom and the ever worsening U.S. debt scenario. The gargantuan demand from China can cause the yellow metal's prices to skyrocket, analysts feel. If the Chinese buying trend is ably supplemented with a fall in the value of dollar, this could result in a skyrocketing of prices.
IBTimes Logo

April NPD Preview -- Expect Rebound in Software Sales Growth: Analyst

Wedbush Securities expects April U.S. retail video game console software sales data to be released by the NPD Group after the market close on May 12. The brokerage said April may be an anomalous month for software sales, with a rebound likely due to an outstanding lineup of blockbuster title.

Did the silver bubble burst?

There are three reasons to believe that the silver bubble has burst with last week's tremendous 30-percent crash.

Volatility Ahead for Visa and MasterCard

FBR Capital Markets said Visa Inc. (NYSE: V) and MasterCard Inc. (NYSE: MA) have been volatile for over a year due to the Durbin Debit Interchange Amendment. The brokerage said it is worth watching in the next few months in the wake of final regulations expected from the Federal Reserve.
Greece's Prime Minister Papandreou

S&P Downgrades Greece to ‘B’

S&P downgraded Greece on Monday to ‘B’ on increased risks that Greece will have to restructure its sovereign debt. Furthermore, the ‘B’ rating has been put on negative watch.
IBTimes Logo

Week Ahead in Life Sciences

Wedbush Securities said that among the companies it covered in Life Sciences this week Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) and Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) are reporting earnings.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.